Unilever unit aims for Target in skincare TM suit
A developer of luxury skincare and toiletry creams has accused US retailer Target of reselling unauthorised versions of its branded products.
In a complaint filed at the US District Court for the Central District of California, Western Division, on Tuesday, November 13, Dermalogica claimed it has suffered “irreparable harm” from the alleged infringement.
Dermalogica, which is owned by Unilever, alleged that Target has been selling the products both online and in-store to thousands of consumers.
The Unilever company owns three trademarks for ‘Dermalogica’ and, according to the complaint, the company goes to great lengths to control the quality of goods that bear the mark.
The skincare brand only sells its goods through authorised sellers, or to customers directly online through its official site. The agreements with authorised resellers prohibit diversion of the products to other resellers, Dermalogica explained.
It added that its authenticity holograms and quality control tags distinguish its genuine products from counterfeits.
However, Dermalogica alleged that Target has been supplied with the goods by some of Dermalogica’s authorised resellers in violation of the agreements.
Some of the products in circulation had the authenticity holograms labels removed and replaced with “counterfeit replacements in order to thwart the ability to track products”, Dermalogica said.
Dermalogica also accused Target of mimicking the characteristics of Dermalogica’s own marketing materials and artwork to confuse customers.
"Target is using the ‘Dermalogica’ trademark on its display and marketing materials, and is mimicking the characteristics of Dermalogica’s marketing materials, to confuse consumers and create the appearance that Target is an authorised reseller of Dermalogica personal-care products,’ said the suit.
According to the complaint, the infringements have been taking place since autumn 2017 and have continued despite Target being warned about its infringing practice.
Dermalogica is seeking damages, attorneys’ fees and an order preventing Target from continuing its “infringement and unlawful practices”.
Target has been contacted for comment.
Did you enjoy reading this story? Sign up to our free daily newsletters and get stories like this sent straight to your inbox.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk